Skip to main content
Mayinglong Pharmaceutical Group Co.,Ltd logo

Mayinglong Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600993 ISIN · CNE000001HN2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 931 across all filing types
Latest filing 2012-03-28 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600993

About Mayinglong Pharmaceutical Group Co.,Ltd

https://www.mayinglong.cn/

Mayinglong Pharmaceutical Group Co.,Ltd. is a long-established enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Founded in 1582, the company is widely recognized for its expertise in proctology, maintaining a dominant market position with its signature hemorrhoid ointments and suppositories. Its product portfolio also includes ophthalmic preparations, dermatological treatments, and gastrointestinal medicines. The company integrates traditional medicinal formulas with modern manufacturing technologies to provide healthcare solutions. Beyond pharmaceuticals, Mayinglong has expanded into healthcare services, including specialized hospitals and personal care products, focusing on the integration of clinical treatment and health management.

Recent filings

Filing Released Lang Actions
第七届监事会第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the ninth meeting of the seventh Supervisory Board of Mayinglong Pharmaceutical Group Co., Ltd. It details the approval of internal management systems and control implementation plans, with voting results included. There is no financial data, no mention of annual or interim reports, no shareholder voting results at a general meeting, and no indication of a report publication or regulatory filing. The content focuses on board-level decisions and internal governance matters. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by company boards or senior management bodies.
2012-03-28 Chinese
第七届董事会第十次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the company's board meeting, specifically the 7th Board's 10th meeting. It details the approval of internal management systems and internal control implementation plans. There is no financial data, no mention of annual or quarterly reports, no voting results from shareholder meetings, and no mention of changes in senior management or capital structure. The document is a board meeting resolution announcement, which fits best under Board/Management Information (MANG). The document length is short and it is not a report or a report publication announcement. Therefore, the classification is MANG with high confidence.
2012-03-28 Chinese
内幕信息知情人登记管理制度（2012年3月）
Governance Information Classification · 95% confidence The document is a detailed internal policy titled '内幕信息知情人登记管理制度' (Insider Information Insider Registration Management System) for 马应龙药业集团股份有限公司. It outlines the management, registration, confidentiality, and responsibilities related to insider information and insider persons within the company. The content includes definitions, scope, procedures, and legal references related to insider information management, but it does not contain financial data, earnings, audit results, or any report of financial performance. It is a governance-related document focused on internal rules and compliance regarding insider information. Therefore, it fits best under Governance Information (CGR). The document length is over 5,000 characters and is substantive, so it is not a mere announcement or regulatory filing. Hence, the classification is CGR with high confidence.
2012-03-28 Chinese
内部控制规范实施工作方案
Regulatory Filings Classification · 95% confidence The document is titled as an "Internal Control Norms Implementation Work Plan" for a company, detailing the internal control system, organizational structure, work plans, and audit plans related to internal control. It references regulatory requirements from the China Securities Regulatory Commission and related bodies, and outlines steps for internal control self-evaluation and audit. The document is about internal control implementation and audit planning rather than a full annual report or audit report itself. It does not contain actual financial statements or results but rather a detailed plan and description of internal control processes and upcoming audit activities. The document length is 3864 characters, which is relatively short and more consistent with a regulatory or compliance filing rather than a full report. It is not a certification letter, nor an announcement of a report publication. Given the content focuses on internal control implementation and audit planning, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory or compliance documents that do not fit other specific categories.
2012-03-28 Chinese
关于股东股权解除质押暨继续质押的公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement regarding the release and continuation of share pledges by a shareholder. It includes specific details about shares being unpledged and re-pledged, with no financial statements or detailed financial analysis. The document is only 371 characters long and serves as a notification of a capital structure change related to share pledging. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2012-03-27 Chinese
关于审计机构名称变更的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the change of the audit firm's name used by the company. It does not contain any financial statements, audit results, or detailed audit information. It is an official notice about the audit institution's name change, which relates to board or management information but specifically about the audit firm. This fits best under Regulatory Filings (RNS) as it is a regulatory announcement that does not fit other categories like Audit Report or Annual Report. The document length is very short (367 characters), and it is clearly an announcement rather than a report.
2012-01-05 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.